|
2009 - Volume 15
|
| 1 Fourteen-Year Cumulative Index |
| 2 Use of Ursodiol in Infants and Children |
| 3 Advances in Pediatric Pharmacokinetics |
| 4 Rufinamide: Use in Patients with Refractory Epilepsy or Lennox Gastaut Syndrome |
| 5 Prevention and Management of Vitamin D Deficiency in Children: Part I: Requirements |
| 6 Prevention and Management of Vitamin D Deficiency in Children: Part II: Supplementation |
| 7 Saccharomyces boulardii as a Probiotic for Children |
| 8 Furosemide: A Review of Its Use in Infants and Children |
| 9 Escitalopram for the Treatment of Depression in Adolescents |
| 10 Ganciclovir and Valganciclovir Use in Children |
|
2008 - Volume 14
|
| 1 Use of Risperidone in Children with Autism, Bipolar Disease, or Schizophrenia |
| 2 Use of Clindamycin in Pediatric Infections |
3 New Treatment Options for Attention-Deficit/Hyperactivity Disorder (ADHD): Part I.
Transdermal Methylphenidate and Lisdexamfetamine |
| 4 New Treatment Options for Attention-Deficit/Hyperactivity Disorder (ADHD): Part II. Guanfacine |
| 5 Self-Injectable Epinephrine for Initial Management of Anaphylaxis in Children |
| 6 Caffeine Citrate for the Treatment of Apnea of Prematurity |
| 7 Use of Hydromorphone in Children and Adolescents |
| 8 Adenosine for the Management of Neonatal and Pediatric Supraventricular Tachycardia |
| 9 Use of Etomidate for Pediatric Procedural Sedation |
| 10Levothyroxine Use in Infants and Children with Congenital or Acquired Hypothyroidism |
| 11 Improving Pediatric Medication Safety Part I: Research on Medication Errors and Recommendations from the Joint Commission |
| 12 Improving Pediatric Medication Safety Part II: Evaluating Strategies to Prevent Medication Errors |
|
2007 - Volume 13
|
| 1 Twelve-Year Cumulative Index |
| 2 Use of Aspirin in Children with Cardiac Disease |
| 3 Food and Drug Administration Update: Pediatric Highlights |
| 4 Hydrocortisone for Refractory Hypotension in Neonates |
| 5 Self-Medication by Adolescents |
| 6 Omalizumab for the Management of Refractory Allergic Asthma in Children |
| 7 Intravenous Dihydroergotamine (DHE) for the Treatment of Refractory Migraines |
| 8 Tumor Necrosis Factor Alfa (TNFα) Antagonists for Pediatric Immune-Mediated Diseases |
| 9 Retapamulin: A New Option for Impetigo |
| 10 Drug Metabolism via Cytochrome P450 2D6: Ontogeny and Variation in Children |
| 11-12 Pediatric Pharmacology Update |
|
2006 - Volume 12
|
| 1Dexmedetomidine for Sedation in the Pediatric Intensive Care Setting |
| 2 Immunosuppression with Sirolimus after Solid Organ Transplantation in Children |
| 3 Serotonin Syndrome: Pediatric and Neonatal Considerations |
| 4 Routine Hepatitis A Vaccination in the United States |
| 5 Food and Drug Administration Update for Pediatric Health Care Professionals |
| 6 Ertapenem for Prophylaxis and Treatment of Infections in Children |
| 7 Use of Oral Terbinafine in Children |
| 8 Nesiritide for Infants and Children with Heart Failure |
| 9 Human-Bovine Reassortant Rotavirus Vaccine |
| 10 Use of Aminocaproic Acid in Children Undergoing Cardiac Surgery or ECMO |
| 11 Quadrivalent Human Papillomavirus (HPV) Recombinant Vaccine |
| 12 Intraosseous Administration of Drugs in Infants and Children |
|
2005 - Volume 11
|
| 1 Ten-Year Cumulative Index |
| 2 Use of Carvedilol in Children with Cardiac Failure |
| 3 Recent Actions by the Food and Drug Administration |
| 4 Pediatric Therapy Update: Azithromycin |
| 5 Meningococcal Conjugate Vaccine |
| 6 Phenytoin for Seizure Prophylaxis after Traumatic Brain Injury in Children |
| 7 Tetanus, Diphtheria, Acellular Pertussis Booster Vaccination for Adolescents |
| 8 Caspofungin for Refractory Fungal Infections in Infants and Children |
| 9 The Use of Chloral Hydrate in Infants and Children |
| 10 Drug-induced QT Prolongation:Examples from the Pediatric Literature |
| 11 Zonisamide Use in Pediatrics |
| 12 Combination Measles, Mumps, Rubella, and Varicella Vaccine |
|
2004 - Volume 10
|
| 1 Aldosterone Inhibitors in Infants and Children |
| 2 Sildenafil for the Treatment of Pulmonary Hypertension in Children |
| 3 Recent Revisions in Drug Labeling for Children |
| 4 Therapeutic Uses of Codeine in Pediatric Patients |
| 5 Assessing Information from the Vaccine Adverse Event Reporting System (VAERS) |
| 6 Global Poliovirus Eradication and the Inactivated Poliovirus Vaccine |
| 7 Use of Metformin in Pediatric Patients |
| 8 Current Recommendations for Influenza Vaccination in Children |
| 9 Update on Palivizumab |
| 10 Octreotide for the Management of Chylothorax in Infants and Children |
| 11 Use of Rifampin in Pediatric Infections |
| 12 Aripiprazole Use in Children and Adolescents |
|
2003 - Volume 9
|
| 1 Eight-Year Cumulative Index |
| 2 The Use of Milrinone in Infants and Children |
| 3 Clinical Applications for Botulinum Toxin Type A in Pediatric Patients |
| 4 A New Alternative for the Treatment of Attention-Deficit/Hyperactivity Disorder |
| 5 Immunosuppression with Tacrolimus after Solid Organ Transplantation in Children |
| 6 Linezolid Use for Resistant Gram-positive Infections in Children |
| 7 Amlodipine Use in Pediatric Hypertension |
| 8 Immunizations for Adolescents |
| 9 Low-dose Vasopressin Infusions for Vasodilatory Shock |
| 10 Doxycycline for Pediatric Infections |
| 11 The Use of Melatonin in Children with Sleep Disturbances |
| 12 Recent Advances in Pediatric Pharmacokinetics |
|
2002 - Volume 8
|
| 1 Food and Drug Administration Update for Pediatric Practitioners |
| 2 Methylphenidate: New Information and New Options |
| 3 Amphetamines in the Treatment of Attention-Deficit/Hyperactivity Disorder |
| 4 New Agents and Second-line Therapies for Attention-Deficit/Hyperactivity Disorder |
| 5 Topical Macrolactam Immunomodulators for Atopic Dermatitis |
| 6 Acyclovir for Neonatal and Pediatric Viral Infections |
| 7 Levetiracetam for the Treatment of Partial Seizures |
| 8 Naloxone for the Reversal of Opioid Adverse Effects |
| 9 HMG-CoA Reductase Inhibitors forTreatment of Hypercholesterolemia in Children andAdolescents |
| 10 Pediatric Use of Gabapentin |
| 11 Pediatrics Use of Recombinant Human Erythropoietin |
| 12 Black Box Warnings: Implications for Pediatric Health Care Providers |
|
2001 - Volume 7
|
| 1 Six-Year Cumulative Index |
| 2 Oseltamivir: A New Option for the Management Influenza in Children |
| 3 2001 Pediatric Vaccine Update |
| 4 The Second-Generation (Peripherally-Selective) Antihistamines in Children |
| 5 Intranasal Steroids for Children with Allergic Rhinitis |
| 6 Topiramate for the Management of Seizures in Children |
| 7 Isotretinoin: Improving Patient Education and Reducing Risk |
| 8 Using the Atypical Antipsychotic Agents in Children and Adolescents |
| 9 Perioperative Use of High-Dose Rectal Acetaminophen |
| 10 Vitamin K for the Prevention of Bleeding in Newborns |
| 11 Oxcarbazepine Use in Children and Adolescents |
| 12 Amiodarone Use in Children |
|
2000 - Volume 6
|
| 1 Midazolam: Use in the Pediatric Intensive Care Population |
| 2 Mirtazapine: Potential Advantages in Adolescents with Depression Associated with Chronic Illness |
| 3 Preventing Acetaminophen Overdosage |
| 4 Ibuprofen-Associated Renal Toxicity |
| 5 Propofol Usage in Children:Weighing the Benefit and Risk |
| 6 Clostridium difficile |
| 7 Managing Iatrogenic Opiate Dependence with Methadone |
| 8 Pneumococcal Conjugate Vaccine |
| 9 Aprostadil (PGE1) for Maintaining Ductal Patency |
| 10 Rocuronium for Tracheal Intubation |
| 11 Patient-Controlled Analgesia: Guidelines for Use in Children |
| 12 The FDA Modernization Act of 1997: Impact on Pediatric Medicine |
|
1999 - Volume 5
|
| 1 Index of Volumes 1-4 |
| 2 A New Rotavirus Vaccine: Rotashield |
| 3 Lamotrigine in the Treatment of Seizures During Childhood |
| 4 Use of Proton Pump Inhibitors in Children |
| 5 Cefepime |
| 6 The Internet as a Source of Pediatric Medication |
| 7 Cromolyn and Nedocromil in Children with Asthma |
| 8 Alteplase (rt-PA) Use in Infants and Children |
| 9 Vecuronium: Its Role in the Pediatric Intensive Care Unit |
| 10 Preventing Medication Errors in Children |
| 11 Infliximab: A New Therapy for Crohn's Disease |
| 12 Recent Actions by the Food and Drug Administration (FDA) |
|
1998 - Volume 4
|
| 1 Treatment of Intravenous Extravasations |
| 2 Use of Famotidine in Infants and Children |
| 3 Helping Families Avoid Accidental Poisonings |
| 4 Trimethoprim-sulfamethoxazole: A Review of Use in Children |
| 5 Alternative Therapy - Focus on Herbal Products |
| 6 Drug-Induced Photosensitivity |
| 7 Meropenem: An Alternative for Broad-Spectrum Anti-Bacterial Coverage |
| 8 Mycophenylate mofetil: Use in Pediatrics |
| 9 Palivizumab: Use in the Prevention of Respiratory Syncytial Virus Infections |
| 10 Montelukast: A Selective Leukotriene Receptor Antagonist |
| 11 Erythema Multiforme: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis |
| 12 Ciprofloxacin Use in Children: A Review of Recent Findings |
|
1997 - Volume 3
|
| 1 Index of Volumes 1-2 |
| 2 Ceftriaxone in Children |
| 3 Valproic Acid in the treatment of Pediatric Seizures |
| 4 Vitamin and Mineral Supplements for Children in the United States |
| 5 The Cytochrome P450 System and its Effect on Drug Metabolism |
| 6 Using Low-Molecular-Weight Heparin in Infants and Children |
| 7 Vaccine Update: New Policies and Products |
| 8 Improving Compliance with Medication Regimens |
| 9 Use of 5-HT3 Antagonists in Prevention of Nausea and Vomiting in Children |
| 10 Prevention and Treatment of Respiratory Syncitial Virus |
| 11 Pharmacology Literature Review |
| 12 Fluconazole - A Review of Its Use in Children |
|
1996 - Volume 2
|
| 1 Topical Corticosteroids in Children |
| 2 Macrolide Antibiotics |
| 3 Preventing Pediatric Poisonings |
| 4 Maternal Medication Use During Breastfeeding |
| 5 Albuterol: A Review of its Use in Children with Asthma |
| 6 A Comparison of the Oral Cephalosporins |
| 7 Therapy Review: Antipyretics |
| 8 Phenytoin: Optimizing Therapy in Children |
| 9 A Guide to Pharmaceutical Excipients (Inert Ingredients) |
| 10 Use of Selective Serotonin Re-uptake Inhibitors in Children and Adolescents |
| 11 Carbamazepine: A Review of its Use in Children with Epilepsy |
| 12 Medications for Pediatric and Neonatal Advanced Life Support |
|
1995 - Volume 1
|
| 1 Therapy Review: Warfarin (Coumadin) |
| 2 Vancomycin: Old Controversies and New Issues |
| 3 Adverse Drug Reactions |
| 4 Cyclosporine: Techniques for Patient Monitoring |
| 5 Drug-Nutrient Interactions |
| 6 Proper Storage of Vaccines to Maintain Potency |
| 7 Therapeutic Drug Monitoring |
| 8 Treating Lice and Scabies Infestations |
| 9 Antihistamines for the treatment of Allergic Rhinitis in Children |
| 10 Diuretics in Children |
| 11 The FDA Drug Approval Process |
| 12 Hyperactivity Disorder |
